Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Serum adalimumab concentration and clinical remission in patients with Crohn's disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Serum adalimumab concentration and clinical remission in patients with Crohn's disease.
Serum adalimumab concentration and clinical remission in patients with Crohn's disease. Inflamm Bowel Dis. 2013 May; 19(6):1112-22.
View in:
PubMed
subject areas
Adalimumab
Adolescent
Adult
Aged
Antibodies, Monoclonal, Humanized
Anti-Inflammatory Agents
Biomarkers
Crohn Disease
Double-Blind Method
Female
Follow-Up Studies
Humans
Male
Middle Aged
Prognosis
Prospective Studies
Remission Induction
Tissue Distribution
Tumor Necrosis Factor-alpha
Young Adult
authors with profiles
David T. Rubin